Actinium Pharmaceuticals, Inc. (ATNM) — Analyst estimates
Consensus analyst estimates for Actinium Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 1.87M | -0.22 | 1 |
| 2027 | 12.93M | -0.79 | 2 |
| 2028 | 28.25M | -0.49 | 3 |
| 2029 | 98.17M | 0.46 | 1 |
| 2030 | 182.25M | 1.66 | 1 |
Consensus analyst estimates by fiscal year.